XBiotech Statistics

Total Valuation

XBiotech has a market cap or net worth of $71.04 million. The enterprise value is -$44.42 million.

Market Cap	71.04M
Enterprise Value	-44.42M

Important Dates

The next estimated earnings date is Wednesday, August 12, 2026.

Earnings Date	Aug 12, 2026
Ex-Dividend Date	n/a

Share Statistics

XBiotech has 30.49 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	30.49M
Shares Outstanding	30.49M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	25.09%
Owned by Institutions (%)	6.78%
Float	22.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.53
P/TBV Ratio	0.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 39.03

Current Ratio	39.03
Quick Ratio	38.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.93% and return on invested capital (ROIC) is -281.80%.

Return on Equity (ROE)	-25.93%
Return on Assets (ROA)	-18.81%
Return on Invested Capital (ROIC)	-281.80%
Return on Capital Employed (ROCE)	-35.38%
Weighted Average Cost of Capital (WACC)	8.88%
Revenue Per Employee	n/a
Profits Per Employee	-$461,621
Employee Count	87
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, XBiotech has paid $255,000 in taxes.

Income Tax	255,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.78% in the last 52 weeks. The beta is 0.84, so XBiotech's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-12.78%
50-Day Moving Average	2.44
200-Day Moving Average	2.46
Relative Strength Index (RSI)	41.22
Average Volume (20 Days)	34,818

Short Selling Information

The latest short interest is 181,275, so 0.59% of the outstanding shares have been sold short.

Short Interest	181,275
Short Previous Month	184,007
Short % of Shares Out	0.59%
Short % of Float	0.79%
Short Ratio (days to cover)	7.33

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-48.41M
Pretax Income	-39.91M
Net Income	-40.16M
EBITDA	-46.83M
EBIT	-48.41M
Earnings Per Share (EPS)	-$1.32

Full Income Statement

Balance Sheet

The company has $115.46 million in cash and n/a in debt, giving a net cash position of $115.46 million or $3.79 per share.

Cash & Cash Equivalents	115.46M
Total Debt	n/a
Net Cash	115.46M
Net Cash Per Share	$3.79
Equity (Book Value)	135.02M
Book Value Per Share	4.43
Working Capital	114.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$42.17 million and capital expenditures -$195,000, giving a free cash flow of -$42.36 million.

Operating Cash Flow	-42.17M
Capital Expenditures	-195,000
Depreciation & Amortization	1.58M
Net Borrowing	n/a
Free Cash Flow	-42.36M
FCF Per Share	-$1.39

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

XBiotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	-0.05%
Earnings Yield	-56.54%
FCF Yield	-59.64%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1